Jack F M Wetzels Selected Research

Breast Neoplasms (Breast Cancer)

10/2015	Proximal tubular efflux transporters involved in renal excretion of p-cresyl sulfate and p-cresyl glucuronide: Implications for chronic kidney disease pathophysiology.
4/2011	Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations.
1/2010	Deficiency of either P-glycoprotein or breast cancer resistance protein protect against acute kidney injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jack F M Wetzels Research Topics

Disease

37	Proteinuria 01/2023 - 12/2003
28	Membranous Glomerulonephritis (Membranous Nephropathy) 12/2023 - 05/2004
18	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 12/2022 - 07/2002
17	Renal Insufficiency (Renal Failure) 01/2023 - 11/2002
17	Chronic Renal Insufficiency 01/2023 - 08/2008
15	Atypical Hemolytic Uremic Syndrome 01/2024 - 02/2015
14	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 06/2003
13	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2022 - 06/2002
11	Albuminuria 01/2020 - 12/2001
10	Kidney Diseases (Kidney Disease) 01/2024 - 11/2010
7	Thrombotic Microangiopathies 05/2024 - 12/2017
6	Disease Progression 01/2022 - 05/2007
5	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 11/2009
5	Fibrosis (Cirrhosis) 01/2022 - 08/2007
5	Nephrogenic Diabetes Insipidus 01/2018 - 07/2009
4	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 10/2021 - 05/2007
4	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2017 - 04/2012
4	Hyperparathyroidism 02/2016 - 06/2002
4	Anemia 03/2013 - 10/2010
3	Hypertension (High Blood Pressure) 01/2023 - 11/2015
3	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2022 - 01/2020
3	Sclerosis 01/2022 - 01/2014
3	Infections 10/2021 - 09/2014
3	Lupus Nephritis 10/2021 - 06/2003
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2012
3	Inflammation (Inflammations) 01/2020 - 01/2012
3	Cysts 01/2017 - 10/2013
3	Breast Neoplasms (Breast Cancer) 10/2015 - 01/2010
3	Polycystic liver disease 05/2015 - 04/2012
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2015 - 11/2010
3	Neoplasms (Cancer) 06/2014 - 03/2006
3	Atherosclerosis 12/2013 - 11/2004
2	Paraproteinemias (Monoclonal Gammopathy) 09/2023 - 01/2023
2	Glomerulonephritis 09/2023 - 01/2020
2	IGA Glomerulonephritis (IGA Nephropathy) 10/2021 - 01/2020
2	Atrophy 01/2020 - 01/2015
2	Segmental glomerulosclerosis 01/2020 - 11/2006
2	Polyuria 01/2017 - 07/2009
2	Gout 02/2016 - 07/2010
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2015 - 06/2003
2	Chronic Disease (Chronic Diseases) 01/2015 - 10/2010
2	Hyponatremia 12/2013 - 04/2011
2	Heart Failure 06/2012 - 01/2010
2	Diabetes Mellitus 11/2010 - 08/2009

Drug/Important Bio-Agent (IBA)

26	CreatinineIBA 01/2023 - 11/2002
17	Proteins (Proteins, Gene)FDA Link 09/2023 - 01/2003
16	eculizumab FDA Link 05/2024 - 02/2015
11	Complement System Proteins (Complement)IBA 01/2024 - 12/2001
10	SteroidsIBA 03/2023 - 05/2004
9	Biomarkers (Surrogate Marker)IBA 01/2024 - 10/2010
9	AntibodiesIBA 01/2018 - 12/2001
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2023 - 05/2004
8	HepcidinsIBA 01/2020 - 08/2008
7	IronIBA 01/2022 - 11/2004
7	Serum AlbuminIBA 02/2013 - 11/2002
6	Monoclonal AntibodiesIBA 01/2023 - 12/2001
6	TRPC6 Cation ChannelIBA 01/2018 - 10/2011
6	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2017 - 03/2006
6	Vitamin D FDA LinkGeneric 04/2016 - 06/2002
4	Antigen-Antibody Complex (Immune Complex)IBA 12/2023 - 01/2021
4	Phospholipase A2 ReceptorsIBA 03/2023 - 03/2013
4	Vasopressins (Vasopressin)IBA 01/2018 - 04/2011
4	Rituximab (Mabthera)FDA Link 09/2017 - 07/2007
4	lanreotide (Somatuline)FDA Link 01/2017 - 04/2012
4	LithiumIBA 01/2017 - 07/2009
4	EnzymesIBA 02/2016 - 12/2001
4	Angiotensin IIIBA 06/2014 - 12/2001
4	Immunoglobulin G (IgG)IBA 11/2011 - 12/2005
4	Glutamyl Aminopeptidase (Aspartyl Aminopeptidase)IBA 01/2003 - 12/2001
3	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 05/2024 - 01/2023
3	AutoantibodiesIBA 12/2023 - 01/2019
3	AntigensIBA 12/2023 - 03/2013
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 06/2002
3	AlbuminsIBA 01/2019 - 12/2012
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2016 - 09/2012
3	Fibroblast Growth Factor-23IBA 04/2016 - 04/2012
3	Prednisone (Sone)FDA LinkGeneric 10/2007 - 04/2003
2	Messenger RNA (mRNA)IBA 01/2022 - 04/2013
2	PotassiumIBA 01/2021 - 01/2010
2	NPHS2 proteinIBA 01/2019 - 01/2003
2	CalcineurinIBA 01/2018 - 10/2011
2	Uremic ToxinsIBA 07/2017 - 04/2011
2	Parathyroid Hormone (Parathormone)IBA 04/2016 - 08/2012
2	Hepatocyte Nuclear FactorsIBA 02/2016 - 10/2013
2	Connective Tissue Growth FactorIBA 01/2015 - 09/2013
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 06/2014 - 11/2006
2	LDL CholesterolIBA 02/2014 - 09/2012
2	Antihypertensive Agents (Antihypertensives)IBA 02/2014 - 11/2004
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2014 - 09/2012
2	Aquaporin 2IBA 12/2013 - 04/2011
2	Alkylating AgentsIBA 08/2013 - 06/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2013 - 10/2011
2	Contrast MediaIBA 06/2012 - 08/2007
2	Ferritins (Ferritin)IBA 10/2010 - 11/2004
2	Urea (Carbamide)FDA LinkGeneric 07/2010 - 11/2002
2	Peptide Receptors (Peptide Receptor)IBA 07/2010 - 03/2006

Therapy/Procedure

24	Therapeutics 05/2024 - 06/2002
15	Kidney Transplantation 04/2023 - 01/2003
5	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2019 - 06/2003
3	Transplantation 04/2023 - 06/2003